MLAB MESA LABORATORIES INC /CO/
Industrial Instruments For Measurement, Display, and Control · Nasdaq · SEC CIK 724004 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.5%
TTM net income YoY524.0%
TTM EPS YoY474.2%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR—
Margins
Gross margin64.8%
Operating margin10.4%
Net margin2.7%
FCF margin19.7%
EBITDA margin12.4%
Returns
ROE3.6%
ROA1.6%
ROIC (approx.)5.6%
Asset turnover0.60x
Leverage & solvency
Liabilities / assets52.3%
Debt / equity0.33x
Current ratio1.90x
Interest coverage2.58x
Cash quality & payout
Operating cash flow / net income7.73x
Accruals ratio-10.7%
Payout ratio53.3%
Capex / revenue0.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $249.13M | $240.98M |
| Cost of revenue | $90.86M | $90.11M |
| Gross profit | $158.27M | $150.87M |
| R&D expense | $20.31M | $19.52M |
| SG&A expense | $78.66M | $73.33M |
| Operating income | $18.51M | $16.34M |
| Interest expense | $10.69M | $11.86M |
| Pretax income | $12.01M | $5.96M |
| Income tax | $5.30M | $7.93M |
| Net income | $6.71M | -$1.97M |
| EBITDA | $23.77M | $21.72M |
| EPS (basic) | 1.22 | -0.36 |
| EPS (diluted) | 1.21 | -0.36 |
| Dividends declared per share | 0.64 | 0.64 |
| Weighted avg. shares (diluted) | 5.57M | 5.42M |
| Balance sheet | ||
| Cash & equivalents | $26.93M | $27.32M |
| Receivables | $44.10M | $41.97M |
| Inventory | $26.37M | $25.36M |
| Current assets | $106.27M | $102.69M |
| PP&E, net | $30.61M | $32.33M |
| Goodwill | $186.86M | $181.76M |
| Intangibles | $83.35M | $96.88M |
| Total assets | $427.75M | $433.35M |
| Current liabilities | $61.90M | $163.96M |
| Long-term debt | $67.50M | $71.25M |
| Total debt | $67.50M | $71.25M |
| Total liabilities | $241.50M | $273.52M |
| Shareholders' equity | $186.25M | $159.83M |
| Net debt | $40.57M | $43.93M |
| Shares outstanding | 5.52M | 5.46M |
| Cash flow statement | ||
| Operating cash flow | $42.83M | $46.81M |
| Capital expenditure | $3.25M | $4.25M |
| Free cash flow | $39.58M | $42.56M |
| Investing cash flow | -$3.25M | -$4.50M |
| Financing cash flow | -$41.85M | -$44.51M |
| Depreciation & amortization | $5.25M | $5.38M |
| Stock-based compensation | $17.87M | $13.14M |
| Dividends paid | $3.52M | $3.47M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.